Hwa Jin Lee is an expert in TPD field for several years, heading PLK1 degrader, an UPPThera’s current lead pipeline, to FDA IND clearance for phase 1/2a clinical trial. Also, he is in charge of…
Is this you? Claim this profile →
No public contact links on file.
Sectors
Sourcing speakers for your event?
Browse the speaker directory →